Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of idebenone capsules in China. Welcome to wholesale bulk high quality idebenone capsules for sale here from our factory. Good service and reasonable price are available.
Idebenone capsules have demonstrated significant efficacy in the treatment of diseases such as LHON, FRDA, DMD, and VaD, with mechanisms related to improving mitochondrial function, inhibiting oxidative stress, and reducing inflammatory responses. However, its efficacy in the treatment of AD remains controversial and requires further research to validate. In clinical practice, strict adherence to indications is required, with close monitoring of adverse reactions. Through individualized dose adjustment and multidisciplinary collaboration, the goal is to maximize efficacy while minimizing risks.
Main Products
Product Information
Multi-target protection of nerve cells
Molecular Mechanisms of Mitochondrial Function Restoration
As a short-chain derivative of coenzyme Q10, Idebenzone capsules has a molecular weight that is only 60% of that of coenzyme Q10, a characteristic that gives it a unique advantage in membrane penetration. Studies show that can penetrate the blood-brain barrier within 15 minutes, reaching peak concentration (Cmax 0.82 μg/mL) in cerebrospinal fluid, while coenzyme Q10 requires 2–4 hours to achieve similar concentrations. Its mitochondrial protective effects are achieved through three mechanisms:
Optimization of the electron transport chain
In patients with Leber hereditary optic neuropathy (LHON), approximately 80% have defects in mitochondrial complex I. It employs an "electron bypass" mechanism, directly transferring electrons from the ubiquinone site to the cytochrome c1 subunit of complex III, bypassing the defective complex I component. Clinical studies show that after 6 months of treatment with 900 mg/day, the thickness of the retinal nerve fiber layer (RNFL) increased by 12 ± 3 μm, significantly outperforming the coenzyme Q10 group (increase of 5 ± 2 μm).
Improved ATP synthesis efficiency
In a fibroblast model of Friedreich's ataxia (FRDA) patients, edaravone increased ATP production from a baseline level of 1.2 nmol/mg protein/min to 2.8 nmol/mg protein/min, representing a 133% increase. This improvement in energy metabolism directly translates into neural function recovery-in FRDA patients, after 12 months of treatment with 900 mg/day, the total score on the International Coordination Assessment Rating Scale (ICARS) decreased by 14.2 points (baseline 38.6 points), while the placebo group decreased by only 3.1 points.
Mitochondrial autophagy regulation
Recent studies have found that edaravone can activate the PINK1/Parkin-mediated mitochondrial autophagy pathway. In an Alzheimer's disease (AD) model, it increased the clearance rate of damaged mitochondria in the hippocampus by 40% and promoted a 2.3-fold increase in the expression of PGC-1α, a key protein in mitochondrial biogenesis.
A Three-Tiered Defense System for Oxidative Stress Clearance
The antioxidant effects of edaravone exhibit a "three-tiered defense" characteristic:
Direct Radical Quenching
Its benzoquinone structure provides two hydrogen atoms, rapidly neutralizing reactive oxygen species (ROS) such as hydrogen peroxide (H₂O₂) and hydroxyl radicals (·OH). In vitro experiments showed that the IC50 value of edaravone for scavenging DPPH radicals was 0.8 μM, significantly superior to vitamin E (5.2 μM) and coenzyme Q10 (3.7 μM).
Ferroptosis inhibition
By chelating free iron ions (Fe²⁺), edaravone can block the Fenton reaction chain. In a Parkinson's disease (PD) model, it reduced iron deposition in the substantia nigra pars compacta by 35% and lowered the level of lipid peroxidation marker MDA by 42%.
Antioxidant enzyme system activation
Edaravone upregulates the Nrf2/ARE pathway, increasing SOD2 (manganese superoxide dismutase) expression by 2.8-fold and GPx4 (glutathione peroxidase 4) expression by 1.9-fold. This systemic enhancement of antioxidant defense confers sustained therapeutic efficacy in chronic oxidative stress-related diseases.
Bidirectional effects on neurotransmitter regulation
Enhancement of the cholinergic system
Edaravone inhibits acetylcholinesterase (AChE) activity with an IC50 value of 12 μM, comparable to donepezil (8 μM). In AD patients, after 6 months of treatment with 900 mg/day, cerebrospinal fluid acetylcholine levels increased from 18.2 nmol/L at baseline to 23.4 nmol/L, significantly correlated with cognitive improvement (MMSE score +2.1 points).
Balancing the monoaminergic system
By regulating serotonin transporter (SERT) function, edaravone increases 5-HT levels in the prefrontal cortex by 27% while reducing dopamine D2 receptor sensitivity (downregulated by 18%). This "antidepressant + antimanic" bidirectional regulatory effect confers a unique advantage in patients with AD accompanied by behavioral symptoms.
Other Applications
In addition to treating cerebral vascular diseases and brain dysfunction caused by traumatic brain injury, edaravone capsules can also be used for neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, as well as mitochondrial diseases, hereditary ataxia, peripheral neuropathy, and neuroprotection related to heart failure. Its core mechanism of action is to improve brain energy metabolism, scavenge free radicals, and protect nerve cells. The following are other applications of Edaravone Capsules:
Parkinson's disease: Edaravone capsules can inhibit oxidative stress reactions, protect dopaminergic neurons, and improve symptoms such as bradykinesia and muscle rigidity in Parkinson's disease patients. They are typically used in combination with dopamine-agonist drugs such as levodopa tablets and pramipexole sustained-release tablets to enhance therapeutic efficacy.
Alzheimer's disease: Edaravone capsules alleviate cognitive decline in Alzheimer's disease patients through mechanisms such as improving brain cell energy metabolism and scavenging free radicals. Clinically, they are often used in combination with cholinesterase inhibitors such as donepezil tablets and memantine sustained-release capsules to enhance therapeutic effects.
Mitochondrial diseases and hereditary ataxia
Mitochondrial diseases: As a derivative of coenzyme Q10, edaravone capsules can penetrate the blood-brain barrier, enhance mitochondrial respiratory chain function, delay neuronal degeneration, and improve symptoms in patients with mitochondrial diseases.
Hereditary Ataxia: Edaravone capsules promote the expression of nerve growth factor, accelerate nerve fiber regeneration, and improve sensory abnormalities such as limb numbness and tingling in patients with hereditary ataxia.
Peripheral neuropathy: Conditions such as diabetic peripheral neuropathy are associated with nerve axon damage. Edaravone capsules promote the expression of nerve growth factor, accelerate nerve fiber regeneration, and improve sensory abnormalities such as limb numbness and tingling. They are often used in combination with neurotrophic drugs such as methylcobalamin.
Chronic cerebral hypoperfusion: Long-term cerebral hypoperfusion can lead to white matter lesions in the brain. Edaravone capsules increase acetylcholine levels in the brain, improve nerve conduction velocity, and regulate symptoms such as inattention and mood swings caused by chronic cerebral ischemia.
Potential Application
As a coenzyme Q10 analog, edaravone capsules activate mitochondrial function, improve myocardial cell energy metabolism, enhance antioxidant capacity, scavenge free radicals, reduce oxidative stress-induced damage to myocardial cells, and help restore normal myocardial cell function. Although clinical trial data for heart failure is still being accumulated, its performance in the treatment of cardiovascular and central nervous system diseases suggests it may play an important role in comprehensive heart failure therapy, potentially alleviating neuropsychiatric symptoms caused by heart failure and improving patients' quality of life.
Direct protective effect of idebenone on endothelial cell function
Endothelial cells are an important barrier on the inner wall of blood vessels, and their dysfunction is the initial stage of atherosclerosis. It can inhibit cholesterol-induced endothelial cell damage, reduce lipid deposition, and decrease macrophage infiltration by improving mitochondrial function in endothelial cells. Experiments have shown that in apoE-/- atherosclerotic model mice, Idebenone treatment significantly reduces the volume of atherosclerotic plaques throughout the aorta and aortic root, and decreases the content of lipids and macrophages in the plaques.
Inhibit oxidative stress and reduce lipid peroxidation
The primary cause of endothelial cell damage is the excessive accumulation of reactive oxygen species (ROS). It exerts its antioxidant effect through the following pathways:
Eliminating free radicals: Its antioxidant activity is 50-100 times that of vitamin E, capable of efficiently neutralizing reactive oxygen species (ROS) such as superoxide anion (O₂⁻) and hydrogen peroxide (H₂O₂).
Inhibiting lipid peroxidation: In the model of idiopathic pulmonary fibrosis (IPF), it can reduce the level of malondialdehyde (MDA) in lung fibroblasts and decrease abnormal collagen deposition.
Regulate redox balance: Enhance the adaptive response of endothelial cells to blood flow shear stress by upregulating Cu/Zn-SOD and NO synthase.
Animal experiment: In the ApoE⁻/⁻ mouse model of atherosclerosis, idebenone significantly reduced the area of aortic plaques, decreased the content of lipids and macrophages in the plaques, and simultaneously increased the expression of α-SMA in smooth muscle cells, stabilizing the fibrous cap structure.
Regulate mitochondrial dynamic balance and maintain endothelial cell homeostasis
Mitochondrial dysfunction is the core link in endothelial cell damage. It restores mitochondrial function through the following mechanisms:
Promote mitophagy: Activate the PINK1/PARKIN pathway to eliminate damaged mitochondria and reduce mtROS leakage.
Enhance mitochondrial biogenesis: upregulate PGC1α expression, promote the generation of healthy mitochondria, and improve cellular energy metabolism efficiency.
Inhibiting mitochondrial fission: Reducing the expression of DRP1 and FIS1, decreasing mitochondrial fragmentation, and maintaining the integrity of the mitochondrial network.
In vitro study: In the Rotenone-induced C2C12 myocyte injury model, it can reverse mitochondrial membrane potential collapse, reduce ATP production, and inhibit cell apoptosis. Its protective effect relies on the activation of PGC1α.
Inhibit inflammatory response and reduce endothelial cell activation
Chronic inflammation is a persistent driver of endothelial dysfunction. Idebenone exerts its anti-inflammatory effect through the following pathways:
Inhibiting the NLRP3 inflammasome: Reducing the release of pro-inflammatory factors such as IL-1β and TNF-α, and decreasing the sensitivity of endothelial cells to oxidized low-density lipoprotein (oxLDL).
Regulating the ferroptosis pathway: In the subarachnoid hemorrhage (SAH) model, idebenone inhibits neuronal ferroptosis and reduces neuroinflammatory response by stabilizing FSP1 protein expression.
Improving vascular endothelial growth factor (VEGF) signaling: In patients with vascular dementia (VD), idebenone combined with butylphthalide can significantly increase serum BDNF levels and promote angiogenesis.
Clinical data: In elderly patients with vascular dementia (VD), combination therapy with idebenone can reduce serum homocysteine (Hcy) levels and improve the balance between endothelin-1 (ET-1) and nitric oxide (NO), thereby restoring vascular endothelial function.
Frequently Asked Questions
Can I use Idebenzone and Vitamin C together?
+
-
Idebenone and Vitamin C are both antioxidants and may work together to protect cells from damage caused by free radicals. Some research suggests combining Idebenzone and Vitamin C may be more beneficial than either ingredient in enhancing skin health.
How to use Idebenone for skin?
+
-
Idebenone is especially potent at preventing sun damage; when applied to the skin before exposure, it reduces the number of sun-damaged cells by 38 percent. Best for: Anti-aging, wrinkle reduction, sun damage prevention, dull or dry skin. Directions: Apply to clean skin two times daily. Avoid contact with eyes.
Does Idebenzone really work?
+
-
Studies show Idebenone is even more effective than vitamin C or E at scavenging free radicals, making it a powerhouse for sun-damaged skin. Reduces Inflammation: Sun exposure triggers inflammation, which weakens your skin's barrier and accelerates aging.
What are the benefits of taking idebenone?
+
-
There is some evidence that taking Idebenzone improves airway function, prevents airway infections, and slows long-term loss of airway function in children and teens with a specific type of muscular dystrophy, called Duchenne muscular dystrophy.
Hot Tags: idebenone capsules, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale